We are live on ! Find out more
NXTC icon

NextCure
NXTC

48 hedge funds and large institutions have $25.5M invested in NextCure in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

2% more funds holding

Funds holding: 47 → 48 (+1)

0% more call options, than puts

Call options by funds: $2K | Put options by funds: $2K

0.05% less ownership

Funds ownership: 4.82% → 4.77% (-0.05%)

29% less capital invested

Capital invested by funds: $36M → $25.5M (-$10.5M)

Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
15
Reduced
8
Closed
3
Calls
$2K
Puts
$2K
Net Calls
–
Net Calls Change
-$23K

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$932K
2
TCM
Tang Capital Management
California
+$743K
3
AAA
Affinity Asset Advisors
New York
+$533K
4
Renaissance Technologies
Renaissance Technologies
New York
+$100K
5
ACM
ADAR1 Capital Management
Texas
+$74.5K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.1M
2
Morgan Stanley
Morgan Stanley
New York
-$652K
3
SSA
Schonfeld Strategic Advisors
New York
-$593K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$393K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$4.25M – – –
LGM
2
Logos Global Management
California
$3.98M +$932K +47,916 +30%
AAA
3
Affinity Asset Advisors
New York
$2.68M +$533K +27,410 +24%
O
4
OrbiMed
New York
$1.81M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.57M – – –
BlackRock
6
BlackRock
New York
$1.21M -$253 -13 -0%
CCC
7
Cable Car Capital
California
$979K – – –
TCM
8
Tang Capital Management
California
$959K +$743K +38,207 +317%
LFCM
9
Long Focus Capital Management
Puerto Rico
$884K – – –
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$774K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$735K +$100K +5,145 +15%
Millennium Management
12
Millennium Management
New York
$729K -$1.1M -56,312 -60%
Federated Hermes
13
Federated Hermes
Pennsylvania
$521K – – –
AI
14
Acuitas Investments
Washington
$514K +$2.72K +140 +0.5%
Citadel Advisors
15
Citadel Advisors
Florida
$460K +$70.6K +3,632 +18%
BCM
16
BML Capital Management
Indiana
$440K -$48.6K -2,500 -10%
CPA
17
Cardiff Park Advisors
California
$417K – – –
Hudson Bay Capital Management
18
Hudson Bay Capital Management
Connecticut
$324K – – –
Geode Capital Management
19
Geode Capital Management
Massachusetts
$312K +$34.4K +1,768 +12%
Assenagon Asset Management
20
Assenagon Asset Management
Luxembourg
$293K -$393K -20,186 -57%
Macquarie Group
21
Macquarie Group
Australia
$239K – – –
SCM
22
Sio Capital Management
New York
$207K – – –
ACM
23
ADAR1 Capital Management
Texas
$142K +$74.5K +3,833 +107%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$138K +$1.15K +59 +0.8%
BCM
25
Bridgeway Capital Management
Texas
$112K – – –
1
2 3

NXTC Hedge Fund Activity: Q2 2024 in Review

48 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q2 2024, worth a combined $25.5M — down 29% from $36M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NXTC positions and 3 closed out — a net gain of 1 holder — while 15 added to existing stakes and 8 trimmed.

The largest buyer was Logos Global Management, adding an estimated $932K. The largest seller was Millennium Management, cutting an estimated $1.1M.

  • 48 institutional investors held NextCure (NXTC) as of Q2 2024, up from 47 in Q1 2024.
  • Funds reported $25.5M of NextCure stock for Q2 2024, down 29% quarter-over-quarter.
  • 4 funds opened new NextCure positions in Q2 2024 and 3 closed out, a net change of +1 holder.
  • The largest NextCure buyer in Q2 2024 was Logos Global Management, an estimated $932K added.
  • The largest NextCure seller in Q2 2024 was Millennium Management, an estimated $1.1M sold.

Based on aggregated 13F filings for Q2 2024.